Private Equity, VC & Investor
Breega vs HV Capital
Structured technology and market comparison · 2026
Direct Feature Comparison
Breega · vs · HV CapitalEuropean and African early-stage venture capital fund manager.
European venture and growth investor backing technology companies across stages.
Analyze all overlapping signals and tech stacks for Breega and HV Capital
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Breega and HV Capital?
When comparing Breega and HV Capital, both platforms operate within the Private Equity, VC & Investor ecosystem. Breega is positioned as European and African early-stage venture capital fund manager, whereas HV Capital focuses on European venture and growth investor backing technology companies across stages. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Breega and HV Capital?
When evaluating Breega and HV Capital, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Breega and HV Capital compare?
Breega is headquartered in France (founded in 2013) with 10–49 employees. HV Capital is based in Germany (founded in 2000) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Breega vs HV Capital
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Breega
Recent Signals
- ·EU-Startups (European Venture)Funding
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
HV Capital
Recent Signals
- ·Gründerszene (DACH Startups & Scaleups)Leadership
Finn CEO Maximilian Wühr steps down after unicorn round
Maximilian Wühr, founder and CEO of German car subscription startup Finn, has stepped down just four months after the company reached a €1 billion valuation. The 31-year-old will remain on the advisory board, while Patrick Oliver Schmidt, an experienced e-commerce executive, takes over as CEO on November 1, 2026. Internal sources suggest the move was not entirely voluntary, driven by investors' plans for an IPO. Wühr's successor was chosen for his experience with high-growth companies and capital markets, having led Global Fashion Group to a Frankfurt listing. The transition also comes amid customer complaints and legal action from a consumer protection agency over Finn's terms and conditions.
- Finn founder Maximilian Wühr steps down as CEO, replaced by Patrick Oliver Schmidt on November 1, 2026.
- Wühr will stay on as an advisor and in the advisory board.
- The decision was influenced by investors' plans for an IPO and their desire for a CEO with more experience in high-growth companies.
- ·Trending Topics (DACH/CEE Innovation & Tech)Defense Technology
ARX Robotics expands to Poland and Austria
The Munich-based defense-tech company ARX Robotics announced its expansion into Poland during the MSPO defense fair in Kielce. The company has established a Polish entity and plans to build a permanent headquarters with training, maintenance, and technical support facilities. Investments in the double-digit millions are planned, along with the creation of highly qualified jobs. This marks Poland as ARX Robotics' fourth market, making it active in three of Europe's top five defense markets. Additionally, the company founded ARX Robotics Austria in Innsbruck to handle local business and administrative processes. The company operates in Ukraine, where its GEREON unmanned ground vehicles are deployed. ARX Robotics employs around 300 people in Munich, Berlin, London, and Kyiv.
- ARX Robotics announced expansion into Poland at the MSPO defense fair.
- A Polish subsidiary has been founded with plans for a permanent headquarters.
- Investments in the double-digit millions are planned in Poland.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Breega and HV Capital share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks